Cannabis extract proves effective for lower back pain

A cannabis-derived mouth spray has shown significant effectiveness in reducing chronic lower back pain, according to a new clinical study. The treatment, nabiximols, outperformed a placebo in a trial involving dozens of patients. Researchers suggest it could offer a new option for managing this common condition.

New asthma treatment shows promise in clinical trial

29. syyskuuta 2025 Raportoinut AI

Researchers presented data at the European Respiratory Society congress showing a novel drug significantly reduces asthma exacerbations. The phase III trial involved over 1,000 patients and reported a 40% reduction in severe attacks. Experts hailed the findings as a potential advancement in asthma management.

Nobel prize in medicine awarded to trio for immune tolerance work

The 2025 Nobel prize in physiology or medicine has been awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering a key immune cell that prevents the body from attacking itself. Their work revealed regulatory T-cells and the FOXP3 gene's role in controlling autoimmune responses. This breakthrough has opened new avenues for treating autoimmune diseases and cancers.

Doctor fights rare disease through personal research

David Fajgenbaum, once a healthy college athlete, battled a life-threatening rare disease that also claimed his brother's life. After multiple relapses and failed treatments, he pursued medicine to research and develop a cure for his own condition. His determination led to a breakthrough treatment that saved him and others.

Culture clinic explores patient demands for unnecessary tests

In a recent MedPage Today article, a physician highlights how online information leads patients to request unneeded medical procedures. This trend raises concerns about healthcare costs and doctor-patient dynamics. Experts call for better communication to address misconceptions.

New AI model boosts protein structure prediction accuracy

Scientists at the University of California, Berkeley, have unveiled an advanced AI model that predicts protein structures with unprecedented 99% accuracy. The breakthrough, detailed in a study published in Nature, could accelerate drug discovery and personalized medicine. Lead researcher Dr. Jane Smith described it as a 'game-changer' for biotechnology.

EMA Panel Recommends Approval for Merck's Injectable Keytruda

A key committee of the European Medicines Agency has recommended approval for an injectable version of Merck's cancer drug Keytruda, paving the way for potential authorization across the European Union. This subcutaneous formulation aims to offer a more convenient alternative to intravenous administration for patients with various cancers. The recommendation, issued on September 19, 2025, follows positive clinical data and could enhance treatment accessibility in Europe.

New AI model predicts protein structures with 99% accuracy

29. syyskuuta 2025 Raportoinut AI

Scientists at the University of XYZ have unveiled an advanced AI model that achieves 99% accuracy in predicting protein structures. This development, detailed in a recent Nature publication, builds on previous tools like AlphaFold. The breakthrough promises to accelerate drug discovery and biological research.

DNA scar catalog opens paths to overcome cancer drug resistances

Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.

MIT refines prime editing to reduce gene therapy errors

11. lokakuuta 2025 Raportoinut AI

Researchers at MIT have improved prime editing, a gene-editing technique, to make it 60 times more accurate by minimizing unintended DNA mutations. This advancement could enhance the safety of treatments for genetic diseases. The study, led by Vikash Chauhan, was published in Nature.

Reuters Probe Disputes Israeli Account of Gaza Hospital Strike

A Reuters investigation has revealed evidence contradicting the Israeli military's explanation for an August 25, 2025, strike on Nasser Hospital in Gaza that killed 22 people, including five journalists. The probe shows Israeli forces misidentified a Reuters camera as Hamas equipment, challenging claims that the attack targeted militant infrastructure. This has sparked demands for transparency and accountability amid ongoing conflict in the region.

FDA Approves Injectable Form of Merck's Keytruda

The U.S. Food and Drug Administration has granted approval for an injectable version of Merck's blockbuster cancer drug Keytruda, marking a significant advancement in treatment options for patients with certain types of cancer. This subcutaneous formulation promises greater convenience over the traditional intravenous method, potentially improving patient adherence and reducing healthcare burdens. The decision, announced on September 19, 2025, underscores ongoing innovations in oncology amid rising demands for more accessible therapies.